Abstract | The development of therapeutic strategies that promote functional recovery is a major goal of multiple sclerosis (MS) research. Neuroscientific and methodological advances have improved our understanding of the brain's recovery from damage, generating novel hypotheses about potential targets and modes of intervention, and laying the foundation for development of scientifically informed recovery-promoting strategies in interventional studies. This Review aims to encourage the transition from characterization of recovery mechanisms to development of strategies that promote recovery in MS. We discuss current evidence for functional reorganization that underlies recovery and its implications for development of new recovery-oriented strategies in MS. Promotion of functional recovery requires an improved understanding of recovery mechanisms that can be modulated by interventions and the development of robust measurements of therapeutic effects. As imaging methods can be used to measure functional and structural alterations associated with recovery, this Review discusses their use to obtain reliable markers of the effects of interventions.
Introduction
Inflammatory demyelination and axonal loss are considered major determinants of neurological deficits in multiple sclerosis (MS). 1 Functional recovery in MS is achieved and sustained by repair of damage through remyelination, with resolution of inflammation and functional reorganization. Remyelination is an important mechanism of restoration of axonal function after acute inflammatory demyelination. 2 Functional reorganiza tion relies on molecular and cellular mechanisms to induce changes in systems-level functional responses, which are the proximal effectors of perception, action and cognition. This Review focuses on systems-level adaptive functional reorganization in MS as measured by functional MRI (fMRI), discussing mechanisms of functional recovery and ways to enhance them.
The overall aim of this Review is to stimulate progress from studies characterizing recovery mechanisms to studies developing strategies to promote recovery in MS. In the first section, we summarize evidence from imaging studies that shows adaptation of functional systems in response to damage, in order to emphasize principles of adaptive functional reorganization. In the second section, we propose ways in which this understanding can be translated into new recovery-oriented strategies for MS, supported by related findings in other neurological conditions. As our understanding of recovery mechanisms and the development of interventions are influenced by our ability to measure the desired effects, the third section discusses the opportunities and limitations of imaging methods that are used to measure neuroplasticity underlying functional recovery, in order to improve their application as reliable and quantitative measures of therapeutic interventions. 3, 4 Such improvements will extend opportunities for neurorepair to other disabling neurological conditions.
Adaptive functional reorganization
Evidence for reorganization of brain function underlying functional recovery comes from studies of focal ischaemic brain damage, where systems-level reorganization reflects molecular, synaptic and cellular events and constitutes post-injury brain plasticity. 5, 6 Perilesional remapping of cortical representations, functional reorganiza tion in intact regions of the damaged hemisphere, and activation of cortical areas in the undamaged hemisphere accompany functional recovery after stroke. 5 Several lines of evidence show that such reorganization is behaviourally relevant for stroke recovery. First, reorganiza tion is associated with preserved or completely recovered behaviour; 7 second, the extent of functional changes correlates with the associated pathology; 8 third, similar changes can be induced through learning or rehabilita tion; 9 fourth, potential for recovery increases with facilitated reorganization; 9 and last, functional impairment results from interference with such processes (Box 1). 10 Evidence across brain systems supports a similar adaptive role for functional reorganization in MS despite widespread pathology-specifically, functional reorganization accompanying recovery in this disease limits the negative effect of damage on behaviour. [11] [12] [13] [14] [15] [16] [17] Evidence across functional systems In this section, we focus on three psychological domains of perception, action and cognition, and discuss evidence for functional reorganization leading to functional recovery in MS.
Perception
Visual recovery after acute demyelinating optic neuritis typically occurs within weeks despite permanent axonal loss. 18, 19 Plasticity in the visual system contributes to recovery as the effects of lesions on the optic nerve spread both pathologically [20] [21] [22] and functionally [23] [24] [25] [26] [27] [28] [29] [30] through the visual pathway. fMRI studies in patients after onset of optic neuritis show reduced activation in the visual cortex in response to visual stimulation of the affected eye. 23, 24, [26] [27] [28] [29] [30] [31] Consistent with adaptive functional reorganization that promotes clinical recovery, 28, 32 this cortical response increases within 2-6 weeks of disease onset, but remains below that of the unaffected eye. 28 Adaptive functional reorganization occurs at various levels along the visual pathways. During the early period Key points ■ Evidence supports a behaviourally relevant role for neuroplasticity-which is preserved despite widespread pathology-in multiple sclerosis (MS) across all patient ages, stages and phases of the disease ■ Together with adaptive plasticity, maladaptive plasticity can occur in brain systems owing to disuse of impaired limbs and may contribute to disability ■ Interventions that drive neuroplasticity can promote functional restoration by inducing adaptive changes or by predisposing functional systems to adaptive plasticity ■ Patient-specific and disease-related factors influence both spontaneous and intervention-driven adaptive functional reorganization and how the reorganization is measured using imaging ■ Improving the interpretability of functional MRI measures is important for characterization and quantification of the effects of recovery interventions and, thereby, for development of recovery-oriented strategies after onset of optic neuritis, activation of the lateral geniculate nucleus (LGN) and visual cortical areas is lower in response to visual stimulation of the affected eye compared with that of the unaffected eye. 31 Later, during recovery, this difference progressively diminishes in both the LGN and the visual cortex. 31 These changes may reflect remyelination of the optic nerve that re-establishes a normal visual input, or functional reorganization within the LGN that compensates for an impaired optic nerve input to the primary visual cortex. Adaptive changes in early or higher visual areas can also assist in maintaining normal visual function. [29] [30] [31] Cortical reorgani zation within extrastriate visual areas occurs early after onset of optic neuritis and is associated with better visual function 28 and longer-term visual outcome. 32 This early reorganization is associated with recovery independently of other markers of damage in anterior or posterior visual pathways. 32 Orbitofrontal and lateral temporal cortices can be transiently involved in recovery after optic neuritis as part of a dynamic reorgani zation of visual function in the occipital cortex. 28 Action Altered functional patterns of sensorimotor activation constitute a disease trait across different forms of MS. [33] [34] [35] The extent and type of motor reorganization varies across phases 12, 36, 37 and stages 38, 39 of the disease. After a clinically isolated syndrome, patients show more-widespread recruitment of sensorimotor networks than do healthy volunteers. 38 This functional pattern persists in patients who progress to clinically definite MS 37 and characterizes the acute phases of the disease. 12, 36 As disease advances towards secondary progression, patterns of functional reorganization show an increasingly bilateral distribution and, even for simple motor tasks, involve highercontrol sensorimotor areas that are recruited for novel or complex tasks in healthy individuals. 39 The magnitude and extent of functional reorganization depends on the extent and severity of lesional 13, 40 and extralesional 11, 41 brain and spinal cord 42 damage. In patients with normal motor function, greater lesion volume and microstructural damage are associated with more-widespread activation of brain areas. 11, 13, 43 The increased, bilateral recruitment of sensorimotor areas may represent an adaptive mechanism that limits the functional effect of MS damage. 11 Alternatively, such changes could be a consequence of reduced ipsilateral deactivation with impaired interhemispheric inhibition owing to callosal damage. 40, 44 In either case, the bilateral pattern of sensorimotor recruitment relateralizes on the contralateral (affected) hemisphere with functional recovery after a relapse. A persistent recruitment of the sensorimotor cortex on the ipsilateral (unaffected) hemisphere is associated with poor clinical recovery. 36 Lateralized brain activity with preservation of motor function is a consistent finding across age groups in MS. 33 In addition to the hemispheric relateralization, adaptive functional reorganization seems to follow a hierarchy within the motor system, with primary sensori motor regions being recruited in the benign forms 34 and in the initial stages 39 of MS, whereas secondary motor 45 and multimodal nonmotor 35 areas are involved in the progressive forms of the disease. Although damage prompts adaptive functional changes, 17, 43 disability can be associated with a specific altered pattern of hand movement that could reflect maladaptation. 17 Cognition Deficits in cognitive performance [46] [47] [48] [49] [50] [51] [52] and the evolution of such deficits 53, 54 correlate with MS-related damage. Functional studies investigating cognitive processes such as memory, efficiency of information processing, attention and executive functions 55 have consistently shown that these processes are associated with the activity of wider and more bilateral networks of taskspecific regions in patients with MS than in healthy indivi duals. [56] [57] [58] The extent of this recruitment increases progressively with an increased cognitive load [59] [60] [61] and becomes more prominent as MS progresses, 59 when brain activity can involve regions outside the specific cognitive domain. Compared with healthy individuals, the magnitude of activation of task-specific networks in patients with MS is reported to be greater in some studies, 62 but lower in others. 63 Within cognitive networks, changes in perfusion [64] [65] [66] and metabolism, 67 as well as in functional and structural connectivity 63, 68, 69 correlate with cognitive performance. Stronger interhemispheric functional and structural interactions are observed in patients than in controls. 63, 68, 69 This increased strength of connectivity is associated with damage to specific, task-relevant white matter tracts. 69 
Factors influencing functional reorganization
In MS, patient-specific and disease-related factors influence adaptive functional reorganization and the measure ments of such reorganization using imaging methods. Age at disease onset may influence the premorbid cognitive functional reserve. 61 After disease onset, a lowered capacity for brain plasticity 70 and remyelina tion 71 in older individuals compared with younger patients could help to explain the effect of age on the cortical reorganization and functional connectivity 33, 72 that underlie recovery in MS. Sex of the patient also affects damage and repair mechanisms in MS 73 through the effects of sex hormones 74, 75 and helps to explain clinically relevant sex-specific differences in brain functional connectivity that are observed in MS. 76 The type, 12, 36, 37 12, 28, 36, 38 with a magnitude that varies depending on the functional system involved, 12, 28, 36, 38 and the role of individual brain regions within networks. 40, 44 These altered responses return to baseline activity with resolution of inflammation, 12,36,37 but a chronic inflammatory state can produce sustained reorganization of function across brain systems 39 through interference with local mechanisms of brain plasticity. 79 Depending on its location, damage can either interfere with 80 functional reorganization. Depending on the extent of pathology, brain damage can affect sub strates for functional reorganization, 39 potentially with clinically relevant consequences, 34, 82 and also the regional and network efficiency. 83, 84 Clinically, this may be apparent with a higher occurrence of cognitive deficits in the progressive phase of the disease. 55, 61 Whereas fac tors related to brain damage initiate functional reorgani zation, 11 moreextensive and irreversible tissue loss is associated with reduced capacity for functional reorgani zation, 12, 78, 85 which is reflected in a worse clinical outcome. 86, 87 Functional reorganization can be maladaptive. 6 Mal adaptation with chronic limb disuse contributes to disability 17 and might explain the functional differences that are observed among clinical stages 39, 88 and among forms 34, 80 of MS, beyond the adaptive functional reorganiz ation. Maladaptive plasticity triggered and sustained by limb disuse may involve multiple functional systems and contribute to disability in multiple functional domains. 89 Although maladaptation may contribute to disability, establishing whether insufficient adaptive reorganization is the basis for disability, and distinguishing between insufficient and maladaptive plasticity, is difficult. Future interventional studies that interfere with cortical function or studies to assess concurrent structural changes may disambiguate the relative contributions of maladaptation versus insufficient adaptive plasticity.
Promotion of functional reorganization
Adaptive brain plasticity offers a flexible substrate for functional reorganization in MS through local remapping of cortical representation, 13 increased activation in relevant higher-order areas 28, 30, 77, 90 and a shift in interhemispheric lateralization towards the ipsilateral hemisphere. 90, 91 A substantial preservation of brain structural architecture allows these mechanisms to act, although at lower efficiency, 83 even when MS damage or task demand increase. [92] [93] [94] Neuroplasticity offers a substrate for interventions that promote functional recovery in MS, but stability of networks is also necessary for adaptive patterns to be retained. 70 Different functional changes are observed in the motor system in childhood-onset versus adultonset MS, which could be explained by age-related differences in the plastic properties of the brain functional systems. 72 In addition, distinct neural systems can have different requirements for plasticity versus stability across the lifespan. 70 Functional reorganization in the extrastriate cortex after optic neuritis provides an example of this phenomenon in the visual system. 30, 70 Possible interventions Interventions to drive adaptive plasticity can promote functional restoration by inducing adaptive changes or by predisposing functional systems to plasticity ( Figure 1 , Figure 2 ). Stroke recovery research suggests that functional recovery after brain damage is associated with normalization of patterns of functional reorganization. [95] [96] [97] Despite the effects of chronic inflammation on brain
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plasticity, 98 this situation holds true in MS recovery, in both the short-term 14, 28, 36, 37 and the longer-term.
14,34
Training-based interventions Interference with maladaptation caused by learned disuse 17,99 may be the mechanism through which physi cal therapy can limit the extent of MS disability.
14,100 Shortterm right-hand practice (over minutes) of visuo motor tasks in patients with MS can induce perfor mance improvements that are associated with functional reorganization of ipsilateral (right) sensorimotor regions, 14 whose activity is associated with clinical disability. 17 This finding suggests that plasticity changes spread ing across functional systems in MS may reflect mal adaptation that sustains disability and may be a therapeutic target for recovery-oriented interventions. Longer-term practice (over weeks) of visuomotor tasks also induces performance improvements in patients with MS.
14 The improvements are associated with functional reorganization in cognitive systems that are not involved in visuomotor performance improvements in healthy controls.
Constraint-induced movement therapy is based on over coming learned disuse. This approach is under evalu ation in the treatment of MS, 101 supported by its successful application in stroke recovery, 102 where it can induce behaviourally meaningful functional changes in the sensorimotor regions of the hemisphere contralateral to the moving hand. 9 The preserved potential for neuroplasticity 14 and motor performance improvements, 94 even at higher levels of disease burden, suggests that patients with MS could benefit from neurorehabilitation irrespective of the initial severity of motor dysfunction 14 ( Figure 1 ), although cognitive systems different from those acting for the same practice in healthy subjects probably contribute to this plasticity in patients.
14 Studies on cognitive rehabilitation in MS that compared the effects of a specific versus a nonspecific cognitive treatment have reported conflicting results. 103, 104 How ever, evidence that brain functional patterns subserving an increasing load of cognitive performance before and after cognitive training are comparable in patients with mild or severe cognitive impairment 105 suggests that cognitive training can be beneficial in MS, 15 regardless of the severity of cognitive dysfunction. This finding also suggests that functional plasticity can be enhanced by neuropsychological intervention. Beyond the effect on cognitive dysfunction, such interventions may have the potential to expand the brain's functional reserve, 61 especially in childhood MS. 106 Other forms of intervention have been tested in recovery from CNS damage. [107] [108] [109] [110] Motor imagery practice (MIP) involves mental repetition of movements, with the aim of improving motor execution. 111 The rationale for MIP stems from evidence that mentally simulated and physically executed actions, both simple and complex, 112 share similar mechanisms of motor control. 111 Through this overlap of neural substrates, MIP may predispose the motor system to modulation by physical therapy. 113 In stroke recovery, MIP provides sufficient repetitive practice to increase use of the affected arm 110 and to change patterns of brain function. 114 Although factors in MS such as cognitive dysfunction and limb disuse could reduce the capacity for mentally simulated actions, 115, 116 the ability of MIP to drive reorganization of sensorimotor function independently of movement 117 may find clinical application in disabling forms of the disease, in which motor output is severely impaired.
Application of device-based therapies-such as neuro prosthesis for recovery of motor function and computer-based interfaces for cognitive improvement -to rehabilitation of complex behaviours and severe forms of disability is becoming increasingly feasible. 15, 104, 118 Substantial preservation of brain plasticity in patients across levels of disease burden 14, 94 encourages use of these devices for rehabilitation in MS. 
Pharmacological and electrical modulation
The rationale for pharmacological and electrical modulation in MS rehabilitation lies in the substrates and mechanisms of brain plasticity. 119 A rich network of intracortical connections can support many organizational structures, allowing for formation of new cortical representations with learning 120, 121 or for functional remapping with recovery. 13, 122 Persistent changes in efficacy of intracortical connections require a stable form of synaptic modification that is achieved through activity-dependent alteration of the excitatory-inhibitory synaptic balance. These changes constitute synaptic plasticity, 123 which permits neuronal interconnections to be continuously adjusted as a consequence of their exposure to particular activity patterns. Synaptic plasticity is the basis of network plasticity. Induction of plastic processes depends critically on changes within glutamatergic and γ-aminobutyric acid (GABA)-ergic interneurons. 124, 125 Although neuromodulators induce little or no change in basal neuronal activity, they can potentiate or attenuate responses evoked by such neurotransmitters. 126 Pharmacological interventions in recovery strategies can increase or prolong the efficacy of rehabilitation by increasing the susceptibility of relevant nodes or systems to the effects of physical or cognitive interventions. 107 Modulation of glutamatergic activity with potassiumchannel blockers enhances the excitability of the motor cortex and conduction along corticospinal pathways in patients with MS, 127, 128 providing a rationale for test ing the effects of modulation of glutamatergic tone in motor recovery. 129 Cholinergic agonism modulates synaptic plasticity in the hippocampus. 130, 131 Modulation of cholinergic tone through acetylcholinesterase inhibition enhances cognitive function in patients with MS who have memory deficits. 132 Functional changes in the prefrontal cortex, as well as changes in its functional connectivity, may un derlie the efficacy of this intervention (Figure 2) . 16, 133 Dopamine modulates cortical excitability via changes in synaptic plasticity 134 that are relevant for motivational and motor aspects of learning. 135 As in stroke recov ery, 136 modulation of dopaminergic frontal projections in MS might potentiate aspects of motor recovery and memory consolida tion. 135 Serotonin also regulates synaptic plas ticity and cortical excitability. [137] [138] [139] [140] Use of serotonin-reuptake inhibitors in association with physical therapy has produced beneficial effects on motor out comes in patients who are moderately impaired after stroke. 141 Modu lation of multiple neurotransmitter systems to promote stroke recovery has been attempted with amphetamines, 107 which act primarily through nor adrenaline and dopamine signalling and enhance arousal and atten tion that is rele vant for learning and recovery. 142 l-amphetamine sulphate has been tested for treatment of cognitive dysfunction in MS. The drug significantly improved performance in learn ing and memory tasks, 143, 144 as well as speed of processing and working memory. 145 Repetitive transcranial magnetic stimulation (rTMS) interferes with or potentiates the function of specific cortical regions. 146 In stroke recovery, rTMS can improve motor function by re-establishing the functional interhemispheric balance through reduction of inter hemispheric inhibition or by increasing the excitability of damaged circuits. 147 In MS, rTMS might limit the effect of functional interhemispheric imbalance between motor regions and may induce remote effects on the excit ability of spinal circuits in patients with spasticity. 148, 149 Transcranial direct current stimulation (tDCS) modulates synaptic plasticity by altering cortical excitability. 150 Decreased GABAergic tone, which releases latent cortico-cortical projections from tonic inhibition, is a mechanism of rapid cortical plasticity that can facilitate recovery. 120 tDCS can predispose brain plasticity mechanisms to learning 151 and recovery 152 through modulation of this GABAergic tone. The therapeutic potential of electrical stimulation is under investigation for stroke recovery, but its possible application to MS recovery remains to be explored.
The presence of cortical pathology in MS represents a challenge in attempts to develop pharmacological and electrical interventions that modulate the function of specific brain systems, as pathological changes could alter cortical excitability and might, therefore, interfere with the desired effects of interventions. Beyond the pharmaco logical and electrical interventions dis- Patients had comparable cognitive performance to controls, but a significantly greater BOLD signal (red regions) change in the left prefrontal cortex-a difference that reflects functional reorganization. BOLD signal changes in these regions correlated with cognitive performance and brain volume. The activation ratio, a functional score representing the ratio between the magnitude of prefrontal cortex activation on the left (which is high in MS patients) relative to right hemisphere, was calculated to test the effect of pharmacological modulation of brain adaptive plasticity with rivastigmine, a cholinesterase inhibitor. Before rivastigmine administration or following administration of placebo, mean activation ratio in patients was greater than in controls. After rivastigmine administration, mean activation ratio in patients was reduced to within the range of controls. with disease-modifying treatment has on mechanisms of brain plasticity. 79 
Imaging functional reorganization
Promotion of functional restoration requires optimization of methods to detect the effects of interventions and to improve the efficiency of studies. fMRI has been widely used in studies on recovery in MS. 153 It enables characterization of functional reorganization at the systems level, 154 as generation of an fMRI signal correlates with neural activity. However, the fMRI signal is only indirectly neural in origin, and disease-related factors and therapeutic interventions can further complicate interpretation of the signal (Figure 3) . 3 Therefore, the use and interpretation of fMRI as a measure of neural activity in studies on neuroplasticity and recovery requires methodological consideration. 3 
Interpretation of fMRI signal
The blood oxygenation level-dependent (BOLD) signal is the image contrast most commonly used in fMRI studies (Box 2). Comparison with electrophysio logical measurements suggests that the BOLD signal most closely corresponds to presynaptic and postsynaptic processing of incoming afferent signals and intracortical processing, such as are represented in local field potentials, [155] [156] [157] rather than the spiking output of a particular region. Proportional increases or decreases in local excitation and inhibition are likely to lead to increases or decreases, respectively, in the local energy demand and, there fore, in the BOLD signal. [155] [156] [157] Net excitation is also likely to lead to BOLD signal increases, whereas the fMRI res ponse to a net inhibition is probably more circuit-dependent owing to lower energy demands of reduced excitation but increased energy requirement for the inhibitory processes. [155] [156] [157] The origin of the BOLD signal is vascular, so neurovascular coupling must remain intact for fMRI to provide a true representation of alterations in neural activity. Not only should the chemical signalling between neurons, astrocytes and cerebral arterioles be preserved, but so should the biophysical coupling between the vascular response and the BOLD signal. This coupling is embodied in the concept of vascular reactivity, defined as the capacity of the vasculature to augment blood flow and generate a BOLD response following a vascular stimulus.
Alteration of the physiological properties of the BOLD signal can occur with age, in chronic inflammatory states or with therapeutic interventions (Figure 3 ). [158] [159] [160] Age can affect the fMRI response independently of other pathological factors. A reduction of task-induced BOLD contrast associated with reduced baseline cerebral blood flow (CBF) and baseline cerebral metabolic rate of oxygen (CMRO 2 ) has been demonstrated in the ageing brain. 161 Baseline CBF has been shown to modulate taskrelated BOLD signal. 162 Vascular reactivity assessment using carbon dioxide has suggested a reduced ability of blood vessels to respond in the ageing and diseased brain. 163, 164 In addition to alterations in vascular behaviour, neurodegenerative diseases and even a genetic predisposition to such diseases are likely to modify CBF, cerebral blood volume (CBV) and CMRO 2 and, therefore, the BOLD response. 165, 166 Disease or interventions can induce changes in baseline neural activity and vascular response, which are likely to modulate the BOLD signal in response to a task, 167 leading to either overestimation or underestimation of their true modulatory effects on brain activity (Figure 3) . Altered fMRI responses have been demonstrated in circumstances of altered underlying cerebral physiology 168 and, in MS, vascular and metabolic changes have been described. 169, 170 Abnormal perfusion occurs in enhancing 171 and nonenhancing 172 MS lesions, as well as in normal-appearing brain tissue in patients with MS. 169 Both white and grey matter can be affected by per fusional changes that result from damage, and these per fusional changes can differ across disease phases and forms. 173 Baseline CMRO 2 and venous CBV can also be reduced in MS. 174 A more systemic vascular dysregulation can arise from production of inflammatory molecules and from astrocyte dysfunction, 169 which can alter neurovascular coupling through a vasoconstrictive effect 169 or through impaired buffering of ions and neurotransmitters. 175 In addition to disease-associated alterations, therapeutic interventions can induce changes in fMRI responses through their effects on brain plasticity. Their effects on BOLD response may also differ from those in healthy individuals, as therapeutic interventions can interact with damage.
Given the complexity of the processes leading to generation of the BOLD signal, and additional confounders generated by factors such as age, pathology or interventions, methods to improve interpretability of the fMRI signal are needed to characterize mechanisms and aid in development of interventions for functional recovery in MS.
Improving interpretability of fMRI signal
Controlling for factors that modulate the BOLD res ponse to neural activity improves the interpretability of fMRI (Table 1) . 3 However, use of a control task to explore the functional system specificity of an intervention is useful for ruling out global modulation of signalling or vascular reactivity induced by the disease or the intervention. Also, resting-state fMRI provides an alternative approach to the study of functional plasticity that avoids the confounding effect of task-related performance. This approach has been used to explore spontaneous and intervention-driven functional reorganization in MS. 15, 80, 81, [176] [177] [178] It provides a powerful tool in recovery studies as changes in local versus distant connectivity can be characterized despite inter-individual differences in spontaneous or intervention-driven behavioural changes. Resting-state fMRI can also help to disentangle the contribution of insufficient adaptive plasticity versus undesirable maladaptive plasticity to clinical status and to changes in clinical status with intervention. However, given the absence of associated behavioural information in resting-state fMRI, use of this approach in disease and interventional studies requires similar methodological consideration to task-based fMRI.
Measurement of baseline perfusion and of perfusion responses to a task can help to control for differences in baseline BOLD signal, 161, 162, 165, 179 which is relevant when assessing the effect of interventions in patient groups that are affected by different levels of inflammation or are undergoing different types of pharmacological interventions. Vascular reactivity, tested using a vascular stimulus such as carbon dioxide, 180 can be factored into a subsequent analysis of task-related BOLD signal changes 181 to separate the effect of disease or intervention on the vascular versus the neuronal component of the BOLD signal. 159 Combining fMRI approaches with simultaneous or delayed electrophysiological re cording-that is, EEG, magnetoencephalography or TMS-can further contribute to elucidation of the origin of BOLD signal changes. 3 This combination approach is particularly useful for clarifying the neural correlates of an increased or decreased BOLD signal 128 and, thereby, the mechanisms underlying therapeutic interventions. Calibrated fMRI, in which task-related frac tional changes in CMRO 2 are derived from calibration of the BOLD signal relative to changes in CBF, 182, 183 has been used in pharmaco logical studies in the healthy brain 159, 184 with the expectation that CMRO 2 changes reflect the underlying neural activity better than do BOLD signals alone. In addition to controlling for potential confounding factors, the measurement of cerebral physiology might provide novel markers of recovery or treat ment effects. Arterial spin-labelling measures of CBF, for example, are more stable markers of resting levels of brain activity over Box 2 | The neurophysiological basis of functional MRI Functional MRI (fMRI) has millimetre-scale spatial resolution, providing a large-scale average of neural activity. The parameter measured by this imaging technique is the blood oxygenation level-dependent (BOLD) signal, which is principally affected by changes in the local balance between neuronal excitation and inhibition. Increased neural activity results in increased cerebral metabolic rate of oxygen (CMRO 2 ) and local vasodilatation, which increases cerebral blood flow. The fractional increase in blood flow is greater than the fractional increase in CMRO 2 . This difference reduces the quantity of (paramagnetic) deoxyhaemoglobin in the veins and is equivalent to increased oxygenation, which increases local magnetic field homogeneity around capillaries and veins and, thereby, increases net signal intensity in that area. This change in BOLD signal varies depending on the magnetic field strength, the brain region and the underlying physiology or pathology. Within a scan, periods of active stimulation ('ON' condition) are contrasted with rest periods ('OFF' condition). The choice of baseline is crucial in the interpretation of fMRI data. The most powerful experimental designs use equal-duration alternating ON and OFF periods (block design), each lasting 10-60 s. Brief stimuli can be used in event-related designs if the functions under investigation necessitate this approach. Investigations of resting-state activity have grown in popularity in recent years, especially in patient populations, as these studies remove the potential complication of diseaseassociated impaired task performance. These investigations seek to identify temporally covarying BOLD signals, which are thought to reflect dynamically covarying levels of neural activity, from different brain regions. Such signals are thought to represent functional connectivity between the brain regions in question. This approach can identify networks of brain regions that could underlie a specific function, such as motor output or vision, 192 and can be used to detect their potential modulation in disease. long time periods than are BOLD signal measures, 185 which is relevant to disease evolution and treatment. 158 Furthermore, regional measures of vascular reactivity 163 and CBF could help to determine inflammatory status, 172 and might, therefore, be used to assess effects of antiinflammatory treatments, including their modulation of brain plasticity, in MS. Efficient study designs would facilitate the development of interventions to promote recovery. Multi centre fMRI studies are feasible and reliably informative in MS. 91 In multicentre settings, longitudinal studies, which are required when testing interventions to promote re covery, 186 can provide reproducible fMRI measures. 187 Several studies in motor recovery in MS have analysed functional and effective connectivity using sophisticated statistical approaches to establish the strength of activation and synchrony between specific brain areas. 77, 178 Graph theory approaches that model effectiveness of information transfer within brain networks can enable assessment of the effect of patient-specific factors, dis ease and in tervention in dynamically changing brain systems. 76, 83, 188 Functional changes in specific regions can be particularly informative in assessment of restorative thera pies. 'Recovery-weighted' maps, in which patient-specific 28, 30, 63 and performance-related 91 functional responses are associ ated with a favourable clinical status 63 or outcome, 33, 34 can be useful for testing the effects of interventions. 9 Similarly, the development of high-resolution methods to study difficult-to-access anatomical regions relevant for recovery, such as the LGN, can help in understanding aspects of recovery that can be manipulat ed early after acute damage. 31 In studies on recovery, fMRI is often combined with structural information in an attempt to capture brain plasticity. Models that combine visual responses as measured on fMRI with optic nerve structure and measures of visual function can determine the contribution of functional reorganization to clinical function after accounting for structural factors. 28 Combination of functional connectivity measures with measures of structural damage to specific white matter tracts is also used to investigate the relationship between structural and functional abnormalities in patients with MS. 90 Structural imaging can be used in combination with functional imaging in recovery studies to investigate the bases for individual variation in neuroplasticity 189 and recovery, 190 to demonstrate structural plasticity accompanying functional plasticity and to characterize the time course of these concurrent changes. 191 A detailed discussion of structural imaging methods to investigate structural repair is beyond the scope of this Review. Given the close interplay between systems-level functional and structural plasticity, opportunities and limitations of structural imaging methods, which could be relevant to investigation of structural repair in MS 153 and may be similarly affected by disease or interventions, are briefly discussed in Supplementary Box 1 online.
Conclusions and future directions
Despite substantial progress in the field of functional recovery, MS continues to be the major cause of chronic neurological disability in young adults, and development of therapeutic strategies to promote functional recovery remains challenging. Review of the literature highlights difficulties in confidently interpreting results from single studies, or in combining results from different studies owing to uncertainties about the homogeneity of patient groups, and about standardization of interventions, whose biological effects can be characterized and quantified using both clinical scales and objective (imaging or electrophysiological) measures. Moreover, sensitive surro gate markers of recovery are lacking, and prediction of treatment effect sizes, which could con tribute to prospective powering of studies, remains challenging.
A path forward will involve development of new kinds of study designs that are optimized for assessing specific mechanisms of recovery and incorporating clinically relevant outcomes, with testing of specific hypotheses related to the underlying neurobiological mechanisms by which interventions promote recovery. A combined strategy involving a strong biological rationale and monitor ing Box 3 | Considerations for future studies to promote functional recovery Type of study Hypothesis-driven studies are preferable when targets of intervention are known. Translational studies, from bench to bedside, should be encouraged. Exploratory methodologies can be used for identification of potential new therapies or targets.
Design
Optimized trial designs (for example, sequential, adaptive or enrichment methodologies) should be prioritized over traditional trial designs. Appropriate control groups are essential. A postintervention study phase is desirable to confirm the effect of interventions and to test for sustained effects.
Groups
Cohorts with disabilities should be prioritized when investigating the potential benefits of new interventions. Nondisabled cohorts can be studied to define biological mechanisms of successful recovery, and to assess interventions that might increase the capacity for recovery by delaying accrual of disability. Eligibility criteria for study groups should be based on 'rehabilitation criteria' (relating to performance) when effects of interventions are tested, or on 'standard clinical criteria' (related to disease characteristics) when the influence of specific disease characteristics on effects of interventions is tested.
Sample size
Fixed sample size or adaptive sample size re-estimation can be considered, depending on the type of study design.
End point
The study end point should be clinically relevant. Both clinical and paraclinical measures such as imaging should be collected to define mechanisms of therapeutic benefit. Efforts should be accelerated to better validate imaging or other paraclinical measures of brain recovery. Patient-related outcome measures provide an important complementary perspective.
Interventions
Behavioural, pharmacological or electrophysiological interventions should all be considered. Interventions and paraclinical measures should be standardized to allow comparisons between studies. Towards this goal, the scientific community should aim to share methodologies and data.
Analysis methods
Hypothesis testing and exploratory studies should be clearly identified as such, and appropriate statistical approaches used for each. Confidence intervals should be regularly reported and consideration should be given to the potential effects of heterogeneity of patient populations. When imaging is combined with behavioural studies, multimodal approaches are desirable.
of functional and structural reorganization using brain imaging methods should form the basis of scientifically informed neurorehabilitation in MS. Using this approach, effects of interventions can be quantified and compared with clinically relevant, sensitive and reproducible measures in selected clinical cohorts (Box 3). As in stroke research, restorative strategies in MS are building on emerging understanding of neural plasticity. Their progress, therefore, is inherently cross-disciplinary and relies on more-complex, multimodal approaches, beyond the purely behaviour-centred studies.
Experience gained from other neurological conditions provides a powerful framework in which models of recovery and neurorehabilitation can be constructed and tested. 154 Development of new strategies to promote recovery, and of imaging markers to measure effects of therapeutic intervention, however, needs to take place within the specific pathological context of MS. The chronic and diffuse nature of MS pathology presents challenges, as effects of interventions need to be sustained and to operate across multiple brain systems. In addition to adaptive plasticity, maladaptive reorganization accompanying chronic disuse can occur, presenting a further challenge to recovery. Limited, direct evidence from studies in MS encourages manipulation of adaptive plasticity with therapeutic interventions, but our knowledge of brain plasticity in MS derives mainly from observational studies without external inducement of plasticity. Further testing in controlled interventional studies is essential if we are to develop an understanding of how to effectively promote adaptive plasticity in MS and how to translate such methods into clinical practice.
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